 |
|
|
 |
|
Client
- An emerging biotechnology company
Critical Challenges
- Product represented a new approach to disease screening
- No experience in marketing directly to end user physician marketplace
- Existing client nine-person sales force limited to selling
capital equipment
- No alignment of territories or systematic rationale for physician
target list
- Lack of experienced, professional marketing support to develop physician marketing and sales aids and collateral materials
- Areas of skepticism concerning the effectiveness of a physician-based field force
Objectives
- Provide comprehensive commercialization functions, including:
(1) market analyses and product potential market assessments,
(2) territory mapping for optimal sales force coverage, and
(3) hiring, training and deployment of district managers and
sales teams
- Generate product acceptance with the busiest ob/gyn
practices nationwide
- Develop and implement effective promotional materials to support strategy, positioning and messaging
Solution
- Source, hire, train and deploy a 105-rep field team on time and on profile
- Deploy team to overlap client 130-member specialty neuroscience team
- Provide coverage for exclusively assigned physicians and mirrored client targets
Results
- PDI-exclusive sales force produced better share-change results than either overlapping forces or client exclusive team
- PDI-exclusive team drove 15.7% increase for Product 1, 27% increase for Product 2
- Combined efforts pushed Product 1 to all-time high market share of 14.05%, for 25% growth during program year
- Product 2 reached all-time high market share of 10.5%, for 20% overall growth
|
|
Product
Molecular diagnostic test
DATA
Product Revenue (2003-2005)
Since deployment of the first PDI sales team in July 2003, sales have doubled, generating an incremental$33.6 million in revenue.
Source: Verispan.
PDI data on file.
|
 |
|
|